|

Cadonilimab + bevacizumab + FOLFOX Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Fudan University1

Indications

  • Cadonilimab1
  • Microsatellite Stable Colorectal Carcinoma1
  • RAS Mutation1
  • Metastatic Colorectal Cancer1
  • Cancer1

Other1 trial

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.